Beyond Genomics - Mining the Proteome
Lab tests that detect prostate cancer can’t reveal if the cancer poses a real risk. It looks for elevated levels of a protein called PSA, but about 80 percent of cancers that generate high PSA levels grow so slowly and may never need treatment. New research by Amy Herr points the way to a much more refined assessment of proteins and the promise of better diagnosis and treatment of a range of diseases.